For BC, especially in cases expressing PD-L1, immunotherapy has been explored and applied, showcasing promising results particularly in combination with chemotherapy, thus offering a beacon of hope for translating the success observed in other cancers to the realm of breast cancer treatment [36]. This evidence concerns the gene CD274 and breast carcinoma.